R. Loch Macdonald - 14 Jul 2023 Form 4 Insider Report for Acasti Pharma Inc. (ACST)

Role
Chief Medical Officer
Signature
/s/ Prashant Kohli, as attorney-in-fact
Issuer symbol
ACST
Transactions as of
14 Jul 2023
Transactions value $
$0
Form type
4
Filing time
18 Jul 2023, 16:34:18 UTC
Previous filing
26 May 2023
Next filing
08 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACST Stock Options (Right to Buy) Award $0 +60K $0.00 60K 14 Jul 2023 Class A Common Shares 60K $2.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted on 07/14/2023 under the Acasti Pharma Stock Option Plan, which vest and become exercisable in equal quarterly installments over a period of 36 months.